Netupitant/Palonosetron (Akynzeo) for Chemotherapy-Induced Nausea and Vomiting

被引：0
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2015年 / 57卷 / 1467期
关键词：
FIXED-DOSE COMBINATION; EMETOGENIC CHEMOTHERAPY; GUIDELINE UPDATE; PHASE-III; PREVENTION; PALONOSETRON; NETUPITANT; EFFICACY; SAFETY; NEPA;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：61 / 63
页数：3
相关论文
共 9 条
  • [1] A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
    Aapro, M.
    Rugo, H.
    Rossi, G.
    Rizzi, G.
    Borroni, M. E.
    Bondarenko, I.
    Sarosiek, T.
    Oprean, C.
    Cardona-Huerta, S.
    Lorusso, V.
    Karthaus, M.
    Schwartzberg, L.
    Grunberg, S.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (07) : 1328 - 1333
  • [2] [Anonymous], 2013, Med Lett Drugs Ther, V55, pe44
  • [3] [Anonymous], 2003, Med Lett Drugs Ther, V45, P62
  • [4] [Anonymous], 2004, MED LETT DRUGS THER, V46, P27
  • [5] Basch E, 2011, J CLIN ONCOL, V29, P4189, DOI [10.1200/JOP.2011.000397, 10.1200/JCO.2010.34.4614]
  • [6] A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
    Gralla, R. J.
    Bosnjak, S. M.
    Hontsa, A.
    Balser, C.
    Rizzi, G.
    Rossi, G.
    Borroni, M. E.
    Jordan, K.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (07) : 1333 - 1339
  • [7] Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
    Hesketh, P. J.
    Rossi, G.
    Rizzi, G.
    Palmas, M.
    Alyasova, A.
    Bondarenko, I.
    Lisyanskaya, A.
    Gralla, R. J.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (07) : 1340 - 1346
  • [8] Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
    Roila, F.
    Herrstedt, J.
    Aapro, M.
    Gralla, R. J.
    Einhorn, L. H.
    Ballatori, E.
    Bria, E.
    Clark-Snow, R. A.
    Espersen, B. T.
    Feyer, P.
    Grunberg, S. M.
    Hesketh, P. J.
    Jordan, K.
    Kris, M. G.
    Maranzano, E.
    Molassiotis, A.
    Morrow, G.
    Olver, I.
    Rapoport, B. L.
    Rittenberg, C.
    Saito, M.
    Tonato, M.
    Warr, D.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : v232 - v243
  • [9] Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis
    Rojas, Camilo
    Raje, Mithun
    Tsukamoto, Takashi
    Slusher, Barbara S.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 722 : 26 - 37
1